BenQ Medical Technology
BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments. The company offers wholesale and retail sales of medical device, medical equipment, pharmaceutical, health food, and the… Read more
BenQ Medical Technology (4116) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.084x
Based on the latest financial reports, BenQ Medical Technology (4116) has a cash flow conversion efficiency ratio of 0.084x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$179.07 Million) by net assets (NT$2.12 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BenQ Medical Technology - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how BenQ Medical Technology's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BenQ Medical Technology Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BenQ Medical Technology ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Megawin Technology Co Ltd
TWO:3122
|
-0.003x |
|
Projektengagemang Sweden AB (publ)
ST:PENG-B
|
0.038x |
|
Actic Group AB
ST:ATIC
|
0.088x |
|
Qleanair Holding AB
ST:QAIR
|
0.114x |
|
BQE Water Inc
PINK:BTQNF
|
0.049x |
|
Euro Sun Mining Inc
PINK:CPNFF
|
0.534x |
|
Sesan 4A Hydroelectric JSC
VN:S4A
|
N/A |
|
KEYRUS S.A. EO -25
F:5UP
|
N/A |
Annual Cash Flow Conversion Efficiency for BenQ Medical Technology (2017–2024)
The table below shows the annual cash flow conversion efficiency of BenQ Medical Technology from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$2.30 Billion | NT$222.22 Million | 0.097x | -52.38% |
| 2023-12-31 | NT$2.18 Billion | NT$442.35 Million | 0.203x | -6.99% |
| 2022-12-31 | NT$1.74 Billion | NT$378.77 Million | 0.218x | +97.69% |
| 2021-12-31 | NT$1.10 Billion | NT$121.35 Million | 0.110x | -18.63% |
| 2020-12-31 | NT$1.12 Billion | NT$151.48 Million | 0.136x | -11.39% |
| 2019-12-31 | NT$1.11 Billion | NT$169.23 Million | 0.153x | +32.57% |
| 2018-12-31 | NT$1.09 Billion | NT$126.10 Million | 0.115x | +68.85% |
| 2017-12-31 | NT$1.07 Billion | NT$72.97 Million | 0.068x | -- |